Physician

Lester V. Negron-Ayala, M.D.

According to 2025 Medicare claims, Lester Negron-Ayala, M.D. (NPI: 1558301275) practices general practice in the Wildwood-The Villages, FL market, with the plurality of this provider's patient population coming from Sumter, FL. This provider's primary affiliated billing organization is PREMIER MEDICAL ASSOCIATES OF FLORIDA HEALTHCARE, PA (NPI: 1023612827; TIN: 853886892) and primary practice location at 33513-8973. Negron-Ayala is affiliated with the NeueHealth Premier ACO, LLC (ACO ID: D0181), participating under the REACH model.

Negron-Ayala's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 111 traditional Medicare patients, billed 640 HCPCS/CPT codes, and received $40,767 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 8,029 prescription claims across 573 beneficiaries totaling $958,412 in drug costs, led by Jardiance (Empagliflozin). 2023 DME data shows 12 claims. Open Payments data shows 13 records totaling $250. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $24,030 to $958,412. In contrast, DME billing represents a smaller volume and rose steadily, from $1,459 to $3,665.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	154	663	$45,402
2019	279	746	$45,640
2020	461	1,374	$76,723
2021	172	728	$38,666
2022	116	516	$28,334
2023	109	573	$33,501
2024	111	640	$40,767

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	57	615	$24,030
2016	43	596	$14,636
2017	28	260	$5,116
2018	126	423	$15,995
2019	626	2,489	$201,471
2020	626	6,516	$529,154
2021	624	6,963	$624,517
2022	547	6,753	$626,812
2023	556	7,177	$849,291
2024	573	8,029	$958,412

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	32	$447
2020	N/R	22	$2,239
2021	N/R	12	$2,143
2022	N/R	14	$2,652
2023	N/R	12	$2,399
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	37	37	$125
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	68	186	$81
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	52	113	$57
G0444	Annual depression screening, 5 to 15 minutes	55	55	$18
G0442	Annual alcohol misuse screening, 5 to 15 minutes	58	58	$18

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jardiance	Empagliflozin	164	10,400	$204,393
Eliquis	Apixaban	73	5,530	$106,425
Humira	Adalimumab	15	420	$101,417
Mounjaro	Tirzepatide	37	1,372	$52,054
Trulicity	Dulaglutide	41	1,428	$49,834

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	13	$250	Lilly USA, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Lester V. Negron-Ayala, M.D.?

Tedicare shows public-source Medicare data for Lester V. Negron-Ayala, M.D. (NPI 1558301275), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Lester V. Negron-Ayala, M.D. have ACO affiliation data?

Lester V. Negron-Ayala, M.D. is shown with ACO affiliation data for NeueHealth Premier ACO, LLC (REACH, ACO ID D0181).

What billing organization is linked to Lester V. Negron-Ayala, M.D.?

Lester V. Negron-Ayala, M.D. is linked to PREMIER MEDICAL ASSOCIATES OF FLORIDA HEALTHCARE, PA (billing NPI 1023612827) in the available physician profile data.

Does Lester V. Negron-Ayala, M.D. have Open Payments data?

Lester V. Negron-Ayala, M.D. has 13 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.